A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
The problem of non-alcoholic fatty liver disease, metabolic syndrome and atherosclerosis: from the unity of pathogenesis to the possibility of ursodeoxycholic acid correction
Herald of Pancreatic Club
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver pathologies, the prevalence of which is steadily increasing worldwide. Cardiovascular disease (CVD) is another group of common diseases that have similar pathophysiological mechanisms with NAFLD. CVD and NAFLD occur against the background of metabolic syndrome, systemic insulin resistance, oxidative stress, altered lipid metabolism. The course of both diseases predisposes to the development of endothelial dysfunction anddoi:10.33149/vkp.2020.03.12 fatcat:2hdo7si2v5d5xkwwepid7dgxqy